TrialBritish journal of haematology2014

Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.

Michelle Fanale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.